Eisai Co., Ltd., as part of a strategic investment, began construction of a new injection/research building “Eisai Medicine Innovation Technology Solutions” (EMITS) at the Kawashima Industrial Park in Gifu Prefecture, Japan.   The current research building at Kawashima has served as a base for formulation research since its completion in 1980. In recent years, Eisai’s drug discovery targets have expanded to include new modalities such as antibodies, antibody drug conjugates (...